Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2003
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358182A1 Diazocine derivatives and their use as tryptase inhibitors
11/05/2003EP1358181A1 Substituted pyrrolidines as ccr-3 receptor antagonists
11/05/2003EP1358180A2 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358169A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358160A1 Aminal diones as potassium channel openers
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1357976A2 Pharmaceutical compositions having few side-effects
11/05/2003EP1357975A1 Medicament compositions with negligible side-effects containing betamimetics
11/05/2003EP1357943A2 Methods and compositions for modulating the immune system of animals
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357920A2 Compositions and method of tissue superoxygenation
11/05/2003EP1357915A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1357904A2 Use of pyrazolo 4,3-d]pyrimidines
11/05/2003EP1268480B1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP1154762B1 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
11/05/2003EP1140113B1 Use of bisphosphonates for the prevention and treatment of infectious processes
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1090020B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0921807B1 Hydrogenous medicament
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453026A Compound couth-relieving aster medicine and its prepn
11/05/2003CN1453023A Chinese medicine extractive for treating asthma and the prepn
11/05/2003CN1453022A Chinese medicine for treating foreign body feeling of throat and its prepn
11/05/2003CN1453021A Chinese medicine for treating chronic aphonia due to laryngeal disease and its prepn
11/05/2003CN1453018A Chinese medicine for treating children's dyspneic cough and its prepn
11/05/2003CN1453017A Chinese medicine for treating chronic laryngopharyngitis and its prepn
11/05/2003CN1453016A Chinese medicine for treating acute laryngopharyngitis and its prepn
11/05/2003CN1452994A Multifunctional paster
11/05/2003CN1452982A Mucosa administrated Ribavirin prepn for preventing & curing SARS and its prepn process
11/05/2003CN1452978A Application of citrus paradisi Micf seed in preparing medicine for resisting SARS virus
11/05/2003CN1452974A Globeflower powder for injection and its prepn
11/05/2003CN1452967A Application of cepharanthine in preparing medicine for resisting SARS virus
11/05/2003CN1126753C Pyrazolo (3,4-D) pyrimidines for anticonvulsive and antialiergic/antiasthmatic action
11/05/2003CN1126568C Adjuvant used in vaccine
11/04/2003US6642275 Formulation for respiratory tract administration
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642250 1,8-naphthyridin-2(1H)-one derivatives
11/04/2003US6642244 Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
11/04/2003US6642241 Alkylamino- substituted dihydropyrimido-(4,5-d)pyrimidinone derivatives, inhibitors of p38,
11/04/2003US6642240 Treating emesis in a mammal
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642235 Administering a therapeutically effective amount of a formulation comprising compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of 5000; for selectively inhibiting reuptake of norepinephrine
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642017 Modulating production of pneumococcal capsular polysaccharide
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641063 Milling process for the production of finely milled medicinal substances
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003088988A1 Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088970A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088961A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/30/2003WO2003088952A1 Sustained release of guaifenesin combination drugs
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088944A1 Dry powder inhalant composition
10/30/2003WO2003088943A1 Dry powder compositions
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003049680A3 Compositions containing both sedative and non-sedative antihistamines
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002074732A3 Tryptase-inhibitors
10/30/2003WO2002072571A3 Pyridinyl pyrazoles useful for the treatment of copd
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines